4320 Forest Park Ave Suite 303
Saint Louis, MO 63108
CATEGORIES & HEADINGSdetails >>
Full Service Drug Discovery Contract Research Organization (CRO)
Confluence Discovery Technologies, Inc. (CDT), a wholly owned subsidiary of Aclaris Therapeutics, Inc., serves as research partners for pharma and biotech companies in cell and molecular biology, biochemistry, enzymology, biomarker development, immunology, in vivo efficacy models and medicinal chemistry. We specialize in drug discovery research on complex biological systems, challenging drug targets, immuno-oncology and preclinical and clinical biomarker development.